Scientists discover a switch associated with epileptic seizures
27 October 2015 | By Victoria White
If the researchers blocked a central switch in epileptic mice, the frequency and severity of the seizures decreased...
List view / Grid view
27 October 2015 | By Victoria White
If the researchers blocked a central switch in epileptic mice, the frequency and severity of the seizures decreased...
20 July 2015 | By
Using existing drugs to restore basic biological processes in human cells, researchers may have devised effective treatments for mitochondrial diseases...
19 June 2015 | By SciFluor Life Sciences
SciFluor Life Sciences has announced that pre-clinical research demonstrating the potential effectiveness of its patented novel compound, SF0034, for treating epilepsy and preventing tinnitus was published in the peer-reviewed publication, The Journal of Neuroscience...
12 June 2015 | By Victoria White
A panel of experts will explore ground breaking research regarding the role of non-invasive stimulation of the vagus nerve in pain pathways at AHS 2015...
18 May 2015 | By Victoria White
Anavex revealed full preclinical anti-seizure data for its lead drug candidate, ANAVEX 2-73, at the Antiepileptic Drug Trials XIII Conference...
7 May 2015 | By Victoria White
University of British Columbia researchers have reported that a new anticonvulsant epilepsy drug holds promise as a treatment for Alzheimer’s disease...
8 January 2015 | By SciFluor Life Sciences
SciFluor Life Sciences, LLC, an emerging clinical stage biopharmaceutical company that creates innovative therapeutics for patients with ophthalmologic and neurologic disease, announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,916,133 with claims covering the novel compound SF0034...